Literature DB >> 7843934

Current concepts of the pathogenesis of inflammatory bowel disease.

F Shanahan1.   

Abstract

Although the cause of inflammatory bowel disease is not known, the pathogenesis involves an immune-mediated tissue damage that is the result of an interaction among genetic predisposing factors, exogenous triggers and endogenous modifying influences. Multiple genes are involved and operate at the level of the immune response and at the target organ. Exogenous triggers include the enteric microflora which might stimulate the mucosal immune system in genetically predisposed individuals. Endogenous modifying factors such as the psychoneuroendocrine system have regulatory effects on the immune system and the inflammatory response, and may influence the course of the disease. While autoimmune phenomena do occur, particularly in ulcerative colitis, there is no evidence that they are directly responsible for the tissue damage. It appears more likely, particularly in Crohn's disease, that tissue injury may occur as an indirect or "bystander" effect of mucosal T-cell hyperactivation, perhaps in response to a normal enteric microbial antigen. Most of the immunologic and histologic features of Crohn's disease can be explained by the effects of T-cell derived and other cytokines on the epithelium, the local immune system, the microvasculature, and the recruitment of auxiliary effector cells such as neutrophils.

Entities:  

Mesh:

Year:  1994        PMID: 7843934     DOI: 10.1007/bf02943022

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  31 in total

1.  IgG subclass distribution in serum and rectal mucosa of monozygotic twins with or without inflammatory bowel disease.

Authors:  L Helgeland; C Tysk; G Järnerot; K Kett; E Lindberg; D Danielsson; S N Andersen; P Brandtzaeg
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

2.  Chemotactic activity in inflammatory bowel disease. Role of leukotriene B4.

Authors:  E A Lobos; P Sharon; W F Stenson
Journal:  Dig Dis Sci       Date:  1987-12       Impact factor: 3.199

3.  Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity.

Authors:  F Shanahan; R H Duerr; J I Rotter; H Yang; L R Sutherland; C McElree; C J Landers; S R Targan
Journal:  Gastroenterology       Date:  1992-08       Impact factor: 22.682

4.  Interleukin 8, neutrophils, and acute inflammation.

Authors:  F Shanahan; C N Bernstein
Journal:  Gastroenterology       Date:  1992-07       Impact factor: 22.682

5.  Colonic glycoproteins in monozygotic twins with inflammatory bowel disease.

Authors:  C Tysk; H Riedesel; E Lindberg; B Panzini; D Podolsky; G Järnerot
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682

Review 6.  Inflammation in ileal reservoirs: 'pouchitis'.

Authors:  M V Madden; M J Farthing; R J Nicholls
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

Review 7.  Leukotriene B4 in inflammation.

Authors:  A W Ford-Hutchinson
Journal:  Crit Rev Immunol       Date:  1990       Impact factor: 2.214

8.  Potential role of superantigens in gastrointestinal disease.

Authors:  S P James
Journal:  Gastroenterology       Date:  1993-11       Impact factor: 22.682

Review 9.  Cytokines in intestinal inflammation: pathophysiological and clinical considerations.

Authors:  R B Sartor
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

10.  Gene-targeted immunologic knockouts: new models of inflammatory bowel disease.

Authors:  F Shanahian
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

View more
  4 in total

1.  Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis.

Authors:  T ten Hove; B van den Blink; I Pronk; P Drillenburg; M P Peppelenbosch; S J H van Deventer
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

2.  Overexpression of alpha(1)-acid glycoprotein in transgenic mice leads to sensitisation to acute colitis.

Authors:  T Hochepied; A Wullaert; F G Berger; H Baumann; P Brouckaert; L Steidler; C Libert
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

Review 3.  Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway.

Authors:  Kurt Lucas; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-02-26       Impact factor: 5.590

4.  Evaluation of B and T lymphocytes and plasma cells in colonic mucosa from healthy dogs and from dogs with inflammatory bowel disease.

Authors:  J Stonehewer; J W Simpson; R W Else; N Macintyre
Journal:  Res Vet Sci       Date:  1998 Jul-Aug       Impact factor: 2.534

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.